Grandeur Peak Global Advisors LLC Invests $4.23 Million in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Grandeur Peak Global Advisors LLC purchased a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 65,943 shares of the company's stock, valued at approximately $4,231,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of RYAN. FMR LLC raised its position in shares of Ryan Specialty by 72.3% in the 3rd quarter. FMR LLC now owns 12,875 shares of the company's stock worth $855,000 after acquiring an additional 5,402 shares in the last quarter. HighTower Advisors LLC grew its position in shares of Ryan Specialty by 101.6% in the 3rd quarter. HighTower Advisors LLC now owns 39,969 shares of the company's stock worth $2,661,000 after buying an additional 20,139 shares during the last quarter. Quantinno Capital Management LP purchased a new stake in Ryan Specialty during the third quarter valued at approximately $888,000. XTX Topco Ltd acquired a new position in shares of Ryan Specialty during the third quarter worth $306,000. Finally, Barclays PLC grew its stake in Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock worth $108,994,000 after buying an additional 17,267 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $66.35, for a total value of $2,322,250.00. Following the completion of the sale, the director now directly owns 20,909 shares of the company's stock, valued at $1,387,312.15. This trade represents a 62.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold 176,894 shares of company stock valued at $11,779,720 over the last 90 days. 11.10% of the stock is currently owned by corporate insiders.

Ryan Specialty Price Performance

RYAN traded down $1.03 during midday trading on Thursday, hitting $71.07. 317,340 shares of the company traded hands, compared to its average volume of 939,521. The company has a market capitalization of $18.61 billion, a price-to-earnings ratio of 102.96, a PEG ratio of 1.19 and a beta of 0.66. The business has a 50 day simple moving average of $70.33 and a two-hundred day simple moving average of $68.99. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. On average, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.68%. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's payout ratio is 69.57%.

Wall Street Analyst Weigh In

A number of research firms recently commented on RYAN. UBS Group lifted their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada decreased their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. Barclays decreased their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Keefe, Bruyette & Woods lowered their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Finally, Wells Fargo & Company dropped their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, Ryan Specialty has a consensus rating of "Hold" and an average target price of $75.67.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.